Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

C1orf150 Inhibitors

Germinal Center Associated Signaling and Motility-like protein, known by the gene name GCSAML, is a relatively uncharacterized protein which is theorized to play a role in immune system function, particularly in the context of germinal center formation and activity. Germinal centers are specialized structures within secondary lymphoid organs where mature B lymphocytes proliferate, differentiate, and mutate their antibody genes during an immune response, leading to the production of high-affinity antibodies.The name GCSAML suggests a relationship to GCSAM, a protein implicated in the signaling and motility of B cells within germinal centers. If GCSAML functions similarly, it may be involved in regulating the signaling pathways that control B cell movement and interaction within lymphoid tissues, which is crucial for the proper formation and function of germinal centers. This could include roles in the dynamic rearrangement of cytoskeletal components which is necessary for B cell migration, as well as in the transduction of signals that regulate cell survival, proliferation, and differentiation.

Given the importance of germinal centers in the adaptive immune response, proteins like GCSAML could have significant impacts on the body's ability to mount effective defenses against pathogens. Anomalies in the function of such proteins might contribute to immunodeficiencies or immunopathologies, such as autoimmune diseases or lymphomas.Further research into GCSAML is needed to elucidate its exact biochemical functions and interactions with other proteins involved in germinal center dynamics. Understanding the role of GCSAML could provide valuable insights into the mechanisms governing B cell behavior in germinal centers and could identify new targets for intervention in immune-related conditions.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A potent inhibitor of PI3K, LY294002 blocks the PI3K/AKT signaling pathway, which is essential for cell survival and proliferation, potentially affecting GCASM-like.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a potent and irreversible PI3K inhibitor, impacting cellular processes like survival, differentiation, and motility that could indirectly affect GCASM-like.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

A selective inhibitor of MEK1/2, U0126 blocks the MAPK/ERK pathway, which may influence germinal center dynamics and indirectly modulate GCASM-like activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, potentially affecting transcription factor activity and inflammatory responses, indirectly impacting GCASM-like function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

This compound inhibits p38 MAPK, involved in stress responses and cell differentiation, potentially altering GCASM-like associated processes.

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

A Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib may affect B cell receptor signaling, indirectly influencing GCASM-like.

CAL-101

870281-82-6sc-364453
10 mg
$189.00
4
(1)

Idelalisib selectively inhibits PI3Kδ, playing a critical role in adaptive immune responses, possibly affecting GCASM-like related pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, rapamycin can suppress cell growth and proliferation, potentially impacting signaling pathways relevant to GCASM-like.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$116.00
$330.00
$510.00
$816.00
$1632.00
10
(0)

By inhibiting BCL-2, venetoclax promotes apoptosis in cancer cells, potentially affecting environments where GCASM-like is relevant.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An ERK inhibitor, PD98059 may indirectly influence GCASM-like activity by modulating the MAPK signaling pathway.